Clinical trials
Phase 2 Bronchiolitis Obliterans Syndrome trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
| Unknown status | 4 |
| Completed | 3 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nanfang Hospital, Southern Medical University | 2 |
| Novartis Pharmaceuticals | 2 |
| Ausper Biopharma Co., Ltd. | 1 |
| Beijing InnoCare Pharma Tech Co., Ltd. | 1 |
| BioNova Pharmaceuticals (Shanghai) LTD. | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| Navy General Hospital, Beijing | 1 |
| Sanofi | 1 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bronchiolitis Obliterans Syndrome | 14 |
| Graft vs Host Disease | 2 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Hematologic Neoplasms | 1 |
| Hepatitis B | 1 |
| Leukemia | 1 |
| Purpura, Thrombocytopenic, Idiopathic | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.